P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias

por Richard, K, Schober, S, Rami, M, Mall, S, Merl, J, Slotta-Huspenina, J, Stevanovic, S, Busch, DH, Peschel, C, Krackhardt, AM
Publicado 2014

Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer

por Malinowsky, K, Nitsche, U, Janssen, K-P, Bader, F G, Späth, C, Drecoll, E, Keller, G, Höfler, H, Slotta-Huspenina, J, Becker, K-F
Publicado 2014

A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomas

por Slotta-Huspenina, J, Wolff, C, Drecoll, E, Feith, M, Bettstetter, M, Malinowsky, K, Bauer, L, Becker, K, Ott, K, Höfler, H, Becker, K-F, Langer, R
Publicado 2013